Skip to Main content Skip to Navigation
Journal articles

Transforming Growth Factor-Beta (TGFβ) Signaling Pathway in Cholangiocarcinoma

Abstract : Cholangiocarcinoma is a deadly cancer worldwide, associated with a poor prognosis and limited therapeutic options. Although cholangiocarcinoma accounts for less than 15% of liver primary cancer, its silent nature restricts early diagnosis and prevents efficient treatment. Therefore, it is of clinical relevance to better understand the molecular basis of cholangiocarcinoma, including the signaling pathways that contribute to tumor onset and progression. In this review, we discuss the genetic, molecular, and environmental factors that promote cholangiocarcinoma, emphasizing the role of the transforming growth factor beta (TGF beta) signaling pathway in the progression of this cancer. We provide an overview of the physiological functions of TGF beta signaling in preserving liver homeostasis and describe how advanced cholangiocarcinoma benefits from the tumor-promoting effects of TGF beta. Moreover, we report the importance of noncoding RNAs as effector molecules downstream of TGF beta during cholangiocarcinoma progression, and conclude by highlighting the need for identifying novel and clinically relevant biomarkers for a better management of patients with cholangiocarcinoma.
Document type :
Journal articles
Complete list of metadata

Cited literature [108 references]  Display  Hide  Download
Contributor : Laurent Jonchère Connect in order to contact the contributor
Submitted on : Tuesday, May 26, 2020 - 6:23:36 AM
Last modification on : Thursday, August 12, 2021 - 5:02:58 PM


Publisher files allowed on an open archive


Distributed under a Creative Commons Attribution 4.0 International License



Panagiotis Papoutsoglou, Corentin Louis, Cédric Coulouarn. Transforming Growth Factor-Beta (TGFβ) Signaling Pathway in Cholangiocarcinoma. Cells, MDPI, 2019, 8 (9), pp.E960. ⟨10.3390/cells8090960⟩. ⟨hal-02281403⟩



Record views


Files downloads